semaglutide and fda A big win for Wegovy: Weight loss drug first in history to gain approval for reducing heart risks semaglutide fda approval date approves

Cravings may surface, particularly for carbohydrate-rich foods

Retatrutide efficacy The phase 3 randomised, doubleblind, placebocontrolled TRIUMPH-1 trial evaluated the safety and efficacy of retatrutide for the treatment of patients with obesity or overweight, moderate-to-severe obstructive sleep apnoea and obesity, and knee osteoarthritis pain

Ngondi JL, Etoundi BC, Nyangono CB, et al

How to Talk With Your Clinician Bring concrete questions: current medications, glucose trends, GI history, and goals for weight or diabetes care

Potentiation of glucose-stimulated insulin release from pancreatic beta cells embodies the classic incretin action, reducing postprandial hyperglycemia and chronic hyperinsulinemia [35,36]